BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 20834107)

  • 1. Immunomodulatory effects of tenofovir disoproxil fumarate and entecavir in treating HBV infection.
    Yu X; Long J; Xie Y; Zhang J; Su Z
    J Hepatol; 2024 Mar; 80(3):e123-e125. PubMed ID: 37598940
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply.
    Hong H; Choi J
    Clin Mol Hepatol; 2024 Apr; 30(2):272-273. PubMed ID: 38382919
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Tenofovir disoproxil fumarate, more than an antiviral drug-Another piece of the puzzle.
    Mauss S
    Aliment Pharmacol Ther; 2024 Jan; 59(2):287-288. PubMed ID: 38153282
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Tenofovir disoproxil fumarate more than an antiviral drug-Another piece of the puzzle. Authors' reply.
    Cheng PN; Liu CJ
    Aliment Pharmacol Ther; 2024 Jan; 59(2):289-290. PubMed ID: 38153280
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas.
    Wei Y; Yi Y; Tao C; Ye W; Zhao W
    Cancer Manag Res; 2019; 11():8475-8486. PubMed ID: 31572002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hepatitis B: A Concise Review.
    Rajbhandari R; Chung RT
    Clin Transl Gastroenterol; 2016 Sep; 7(9):e190. PubMed ID: 27628420
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.
    Kim HY; Kim W
    World J Gastroenterol; 2014 Oct; 20(40):14581-8. PubMed ID: 25356022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with hematological malignancies and serological signs of prior resolved hepatitis B.
    Marignani M; Gigante E; Begini P; Marzano A; di Fonzo M; Deli I; Gallina S; Cox MC; Delle Fave G
    World J Gastrointest Oncol; 2012 Mar; 4(3):37-45. PubMed ID: 22468182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in management of hepatitis B virus reactivation in the biologic therapy era.
    Mastroianni CM; Lichtner M; Citton R; Del Borgo C; Rago A; Martini H; Cimino G; Vullo V
    World J Gastroenterol; 2011 Sep; 17(34):3881-7. PubMed ID: 22025876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
    Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
    Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Jenh AM; Pham PA
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.
    Rago A; Lichtner M; Mecarocci S; Marocco R; Cenfra N; Belvisi V; Del Borgo C; Cimino G; Mastroianni CM
    Antivir Ther; 2010; 15(6):929-32. PubMed ID: 20834107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.
    Milazzo L; Corbellino M; Foschi A; Micheli V; Dodero A; Mazzocchi A; Montefusco V; Zehender G; Antinori S
    Transpl Infect Dis; 2012 Feb; 14(1):95-8. PubMed ID: 21749588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.